Current Immunotherapies for Glioblastoma Multiforme.
Huang B, Li X, Li Y, Zhang J, Zong Z, Zhang H.
Front Immunol. 2021 Mar 9;11:603911. doi: 10.3389/fimmu.2020.603911. eCollection 2020.
PMID:33767690
(Nano)platforms in breast cancer therapy: Drug/gene delivery, advanced nanocarriers and immunotherapy.
Ashrafizadeh M, Zarrabi A, Bigham A, Taheriazam A, Saghari Y, Mirzaei S, Hashemi M, Hushmandi K, Karimi-Maleh H, Nazarzadeh Zare E, Sharifi E, Ertas YN, Rabiee N, Sethi G, Shen M.
Med Res Rev. 2023 Nov;43(6):2115-2176. doi: 10.1002/med.21971. Epub 2023 May 11.
PMID:37165896
Phage display screening of therapeutic peptide for cancer targeting and therapy.
Saw PE, Song EW.
Protein Cell. 2019 Nov;10(11):787-807. doi: 10.1007/s13238-019-0639-7. Epub 2019 May 28.
PMID:31140150
Turning cold tumors hot: from molecular mechanisms to clinical applications.
Zhang J, Huang D, Saw PE, Song E.
Trends Immunol. 2022 Jul;43(7):523-545. doi: 10.1016/j.it.2022.04.010. Epub 2022 May 25.
PMID:35624021
Landscape of somatic alterations in large-scale solid tumors from an Asian population.
Wu L, Yao H, Chen H, Wang A, Guo K, Gou W, Yu Y, Li X, Yao M, Yuan S, Pang F, Hu J, Chen L, Liu W, Yao J, Zhang S, Dong X, Wang W, Hu J, Ling Q, Ding S, Wei Y, Li Q, Cao W, Wang S, Di Y, Feng F, Zhao G, Zhang J, Huang L, Xu J, Yan W, Tong Z, Jiang D, Ji T, Li Q, Xu L, He H, Shang L, Liu J, Wang K, Wu D, Shen J, Liu Y, Zhang T, Liang C, Wang Y, Shang Y, Guo J, Liang G, Xu S, Liu J, Wang K, Wang M.